Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: Caspase-9 inhibition provides therapeutic protection

Robert Tamayev, Nsikan Akpan, Ottavio Arancio, Carol M. Troy, Luciano D'Adamio

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Mutations in either Aβ Precursor protein (APP) or genes that regulate APP processing, such as BRI2/ITM2B and PSEN1/PSEN2, cause familial dementias. Although dementias due to APP/PSEN1/PSEN2 mutations are classified as familial Alzheimer disease (FAD) and those due to mutations in BRI2/ITM2B as British and Danish dementias (FBD, FDD), data suggest that these diseases have a common pathogenesis involving toxic APP metabolites. It was previously shown that FAD mutations in APP and PSENs promote activation of caspases leading to the hypothesis that aberrant caspase activation could participate in AD pathogenesis. Results: Here, we tested whether a similar mechanism applies to the Danish BRI2/ITM2B mutation. We have generated a genetically congruous mouse model of FDD, called FDD§ssub§KI§esub§, which presents memory and synaptic plasticity deficits. We found that caspase-9 is activated in hippocampal synaptic fractions of FDD§ssub§KI§esub§ mice and inhibition of caspase-9 activity rescues both synaptic plasticity and memory deficits. Conclusion: These data directly implicate caspase-9 in the pathogenesis of Danish dementia and suggest that reducing caspase-9 activity is a valid therapeutic approach to treating human dementias.

Original languageEnglish (US)
Article number60
JournalMolecular Neurodegeneration
Volume7
Issue number1
DOIs
StatePublished - 2012

Fingerprint

Neuronal Plasticity
Protein Precursors
Caspase 9
Memory Disorders
Dementia
Mutation
Caspases
Alzheimer Disease
Therapeutics
Poisons
Mouse Casp9 protein
Inhibition (Psychology)
Proteins

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Clinical Neurology
  • Molecular Biology

Cite this

Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice : Caspase-9 inhibition provides therapeutic protection. / Tamayev, Robert; Akpan, Nsikan; Arancio, Ottavio; Troy, Carol M.; D'Adamio, Luciano.

In: Molecular Neurodegeneration, Vol. 7, No. 1, 60, 2012.

Research output: Contribution to journalArticle

Tamayev, Robert ; Akpan, Nsikan ; Arancio, Ottavio ; Troy, Carol M. ; D'Adamio, Luciano. / Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice : Caspase-9 inhibition provides therapeutic protection. In: Molecular Neurodegeneration. 2012 ; Vol. 7, No. 1.
@article{e52f6fb68c54485c9511b5d6d279afcf,
title = "Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: Caspase-9 inhibition provides therapeutic protection",
abstract = "Background: Mutations in either Aβ Precursor protein (APP) or genes that regulate APP processing, such as BRI2/ITM2B and PSEN1/PSEN2, cause familial dementias. Although dementias due to APP/PSEN1/PSEN2 mutations are classified as familial Alzheimer disease (FAD) and those due to mutations in BRI2/ITM2B as British and Danish dementias (FBD, FDD), data suggest that these diseases have a common pathogenesis involving toxic APP metabolites. It was previously shown that FAD mutations in APP and PSENs promote activation of caspases leading to the hypothesis that aberrant caspase activation could participate in AD pathogenesis. Results: Here, we tested whether a similar mechanism applies to the Danish BRI2/ITM2B mutation. We have generated a genetically congruous mouse model of FDD, called FDD§ssub§KI§esub§, which presents memory and synaptic plasticity deficits. We found that caspase-9 is activated in hippocampal synaptic fractions of FDD§ssub§KI§esub§ mice and inhibition of caspase-9 activity rescues both synaptic plasticity and memory deficits. Conclusion: These data directly implicate caspase-9 in the pathogenesis of Danish dementia and suggest that reducing caspase-9 activity is a valid therapeutic approach to treating human dementias.",
author = "Robert Tamayev and Nsikan Akpan and Ottavio Arancio and Troy, {Carol M.} and Luciano D'Adamio",
year = "2012",
doi = "10.1186/1750-1326-7-60",
language = "English (US)",
volume = "7",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice

T2 - Caspase-9 inhibition provides therapeutic protection

AU - Tamayev, Robert

AU - Akpan, Nsikan

AU - Arancio, Ottavio

AU - Troy, Carol M.

AU - D'Adamio, Luciano

PY - 2012

Y1 - 2012

N2 - Background: Mutations in either Aβ Precursor protein (APP) or genes that regulate APP processing, such as BRI2/ITM2B and PSEN1/PSEN2, cause familial dementias. Although dementias due to APP/PSEN1/PSEN2 mutations are classified as familial Alzheimer disease (FAD) and those due to mutations in BRI2/ITM2B as British and Danish dementias (FBD, FDD), data suggest that these diseases have a common pathogenesis involving toxic APP metabolites. It was previously shown that FAD mutations in APP and PSENs promote activation of caspases leading to the hypothesis that aberrant caspase activation could participate in AD pathogenesis. Results: Here, we tested whether a similar mechanism applies to the Danish BRI2/ITM2B mutation. We have generated a genetically congruous mouse model of FDD, called FDD§ssub§KI§esub§, which presents memory and synaptic plasticity deficits. We found that caspase-9 is activated in hippocampal synaptic fractions of FDD§ssub§KI§esub§ mice and inhibition of caspase-9 activity rescues both synaptic plasticity and memory deficits. Conclusion: These data directly implicate caspase-9 in the pathogenesis of Danish dementia and suggest that reducing caspase-9 activity is a valid therapeutic approach to treating human dementias.

AB - Background: Mutations in either Aβ Precursor protein (APP) or genes that regulate APP processing, such as BRI2/ITM2B and PSEN1/PSEN2, cause familial dementias. Although dementias due to APP/PSEN1/PSEN2 mutations are classified as familial Alzheimer disease (FAD) and those due to mutations in BRI2/ITM2B as British and Danish dementias (FBD, FDD), data suggest that these diseases have a common pathogenesis involving toxic APP metabolites. It was previously shown that FAD mutations in APP and PSENs promote activation of caspases leading to the hypothesis that aberrant caspase activation could participate in AD pathogenesis. Results: Here, we tested whether a similar mechanism applies to the Danish BRI2/ITM2B mutation. We have generated a genetically congruous mouse model of FDD, called FDD§ssub§KI§esub§, which presents memory and synaptic plasticity deficits. We found that caspase-9 is activated in hippocampal synaptic fractions of FDD§ssub§KI§esub§ mice and inhibition of caspase-9 activity rescues both synaptic plasticity and memory deficits. Conclusion: These data directly implicate caspase-9 in the pathogenesis of Danish dementia and suggest that reducing caspase-9 activity is a valid therapeutic approach to treating human dementias.

UR - http://www.scopus.com/inward/record.url?scp=84872324395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872324395&partnerID=8YFLogxK

U2 - 10.1186/1750-1326-7-60

DO - 10.1186/1750-1326-7-60

M3 - Article

C2 - 23217200

AN - SCOPUS:84872324395

VL - 7

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 60

ER -